We are live on ! Find out more
CCM

Camber Capital Management Portfolio holdings

AUM $1.07B
1-Year Est. Return 8.19%
This Fund
S&P 500
This Quarter Est. Return
+11.56%
1 Year Est. Return
-8.19%
3 Year Est. Return
+26.6%
5 Year Est. Return
+54.57%
10 Year Est. Return
+164.72%
AUM
$2.04B
AUM Growth
-$6.31M
Cap. Flow
-$151M
Cap. Flow %
-7.43%
Top 10 Hldgs %
59.49%
Holding
43
New
9
Increased
11
Reduced
3
Closed
11

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$160M
2
SHPG
Shire pic
SHPG
+$151M
3
BMY icon
Bristol-Myers Squibb
BMY
+$80.4M
4
NUVA
NuVasive, Inc.
NUVA
+$60.9M
5
TSRO
TESARO, Inc.
TSRO
+$56.3M

Top Sells

Rank Stock Value
1
NKTR icon
Nektar Therapeutics
NKTR
+$159M
2
BIVV
Bioverativ Inc. Common Stock
BIVV
+$59.1M
3
VTRS icon
Viatris
VTRS
+$53.3M
4
RDUS
Radius Health, Inc.
RDUS
+$31.8M
5
THC icon
Tenet Healthcare
THC
+$29.9M

Sector Composition

Rank Sector Weight
1 Healthcare 86.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHC icon
26
Bausch Health
BHC
$2.58B
$23.9M 1.17%
+1,500,000
New +$27.9M
WMGI
27
DELISTED
Wright Medical Group Inc
WMGI
$16.2M 0.79%
815,000
+240,000
+42% +$5.15M
ENDP
28
DELISTED
Endo International plc
ENDP
$14.8M 0.73%
+2,500,000
New +$17.5M
DRNA
29
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$9.56M 0.47%
1,000,000
– –
PRTA icon
30
Prothena Corp
PRTA
$425M
$9.18M 0.45%
250,000
+125,000
+100% +$4.55M
MNTA
31
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$2.46M 0.12%
+135,300
New +$2.26M
SGRY icon
32
Surgery Partners
SGRY
$2.01B
$2.32M 0.11%
135,084
– –
ALKS icon
33
Alkermes
ALKS
$8.22B
– –
-400,000
Closed -$21.9M
EXAS
34
PUT
DELISTED
Exact Sciences
EXAS
– –
-1,000,000
Closed -$52.5M
OFIX icon
35
Orthofix Medical
OFIX
$477M
– –
-500,000
Closed -$27.4M
OPCH icon
36
Option Care Health
OPCH
$3.45B
– –
-635,050
Closed -$7.39M
SPY icon
37
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$806B
– –
-1,500,000
Closed -$400M
SRPT icon
38
Sarepta Therapeutics
SRPT
$1.57B
– –
-300,000
Closed -$16.7M
TEVA icon
39
CALL
Teva Pharmaceuticals
TEVA
$40.8B
– –
-3,000,000
Closed -$56.9M
NVTA
40
DELISTED
Invitae Corporation
NVTA
– –
-2,398,123
Closed -$21.8M
RDUS
41
DELISTED
Radius Health, Inc.
RDUS
– –
-1,000,000
Closed -$31.8M
MNK
42
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
– –
-105,000
Closed -$2.37M
BIVV
43
DELISTED
Bioverativ Inc. Common Stock
BIVV
– –
-1,096,000
Closed -$59.1M
1
2

Similar funds

PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
NRD
Nebula Research & Development New York $1.17B AUM 15.19% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return
CCP
Camelot Capital Partners Laguna Beach, California $686M AUM 163.55% 1-Year Est. Return

Camber Capital Management's Q1 2018 Portfolio in Review

As of Q1 2018, Camber Capital Management held 43 positions worth $2.04B, down 0.31% from $2.04B the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Camber Capital Management withdrew a net $151M in Q1 2018, closing 11 positions and reducing 3 holdings. Its most notable exit was Bioverativ Inc. Common Stock, an estimated $59.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 62% a quarter earlier.

Against the trend, Camber Capital Management opened a new position in Biogen worth $141M.

  • Camber Capital Management's largest Q1 2018 buy was Biogen: 515,000 shares worth $141M.
  • Camber Capital Management added most to TESARO, Inc. in Q1 2018, an estimated $56.3M increase.
  • Camber Capital Management's biggest Q1 2018 reduction was Nektar Therapeutics, cutting an estimated $159M.
  • Camber Capital Management fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $59.1M.
  • Camber Capital Management's ten largest holdings make up 59% of its $2.04B portfolio in Q1 2018.
  • Camber Capital Management opened 9 new positions and closed 11 in Q1 2018.
  • Camber Capital Management's portfolio value fell 0.31% quarter-over-quarter to $2.04B.

Based on Camber Capital Management's 13F filing for Q1 2018, filed 15 May 2018.